Updates are available Erratum dated 2017-04-07
Click to view Erratum: https://doi.org/10.1007/s10637-017-0455-y
-
Authors
Fu, S.
Hirte, H.
Welch, S.
Ilenchuk, T. T.
Lutes, T.
Rice, C.
Fields, N.
Nemet, A.
Dugourd, D.
Piha-Paul, S.
Subbiah, V.
Liu, L.
Gong, J.
Hong, D.
Stewart, J. M.
- License Information
-
More Information
Article History
Received: 19 December 2016
Accepted: 26 January 2017
First Online: 1 February 2017
Compliance with ethical standards
: Soricimed Biopharma Inc. sponsored this Phase I clinical study. The only potential conflict of interest because of holding shares in the company is JMS. Research ethics boards of the participating clinical sites approved all protocols and amendments.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
